Paloma Partners’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-3,400
Closed -$332K 1824
2015
Q1
$332K Sell
3,400
-226
-6% -$22.1K 0.01% 819
2014
Q4
$337K Buy
+3,626
New +$337K 0.01% 722